Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Up 796.7% in AugustMarket Beat·Aug 26 at 02:20 AMFSNUY-0.04%FRE
DZ BANK AG Reaffirms Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)Tip Ranks·Aug 15 at 05:06 AMFSNUY-0.04%
Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass ParticlesMorningStar·Aug 10 at 10:53 PMFSNUY-0.04%FRE
Fresenius Kabi recalls Tyenne injection vial lot over glass particle contaminationPUBT·Aug 10 at 10:34 PMFSNUY-0.04%FRE
Fresenius shifts to registered shares, starts trading under new ISIN on Aug. 13, 2026PUBT·Aug 6 at 11:09 AMFSNUY-0.04%FRE
FRE: Upgraded FY 2026 Core EPS growth guidance to 10–15% after strong H1 performanceQuartr·Aug 5 at 07:01 AMFSNUY-0.04%FRE
FRE: Q2 2026 delivered double-digit earnings growth and upgraded guidance on strong segment performanceQuartr·Aug 4 at 08:51 PMFSNUY-0.04%FRE
Fresenius Q2 FY26 core EPS climbs 14% to €0.83; revenue rises 6% to €5.86 billionPUBT·Aug 4 at 08:14 PMFSNUY-0.04%FRE
